Supporting medical innovation to deliver better health for Australians

9 June 2017
australia_big

The Australian government is providing A$5.2 million ($3.9 million) to support researchers and small and medium start-up businesses to deliver innovative health and medical breakthroughs, and better health outcomes for Australians.

For many years, Australia has had an enviable international reputation for delivering ground-breaking health and medical research outcomes that make a real difference to the lives of people in Australia and around the world, said Greg Hunt, Minister for Health and Sport
He said that A$5 million from the Medical Research Future Fund will be used to fund a new Biotech Horizons program to boost Australia's ability to move cutting edge ideas and breakthrough discoveries towards proof-of-concept.

Launching SME Assist

The Minister also announced the launch of SME Assist – a new service run by the Therapeutic Goods Administration (TGA) to provide free, practical and useful online resources that answer many of the basic questions often asked of the TGA.

There will be phone and email support from a dedicated team to help people with specific questions or more complex queries. SME Assist will help many of the small and medium size enterprises at the Translational Research Institute.

Workshops and webinars will also be available from August and are expected to help more than 300 small and medium sized businesses a year to understand what they need to do and streamline their journey.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical